Interpreting the role of acquired gene mutations in defining clinical outcome and treatment response.

被引：0
|
作者：
Papaemmanuil, Elli [1 ]
机构：
[1] Wellcome Trust Sanger Inst, Cambridge, England
来源：
CLINICAL CANCER RESEARCH | 2015年 / 21卷
关键词：
D O I：
10.1158/1557-3265.HEMMAL14-IA42
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IA42
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Maximizing the clinical outcome with mTOR inhibitors in the renal transplant recipient: defining the role of calcineurin inhibitors
    Nashan, B
    TRANSPLANT INTERNATIONAL, 2004, 17 (06) : 279 - 285
  • [32] Clinical Phenotype and Outcome of Hypertrophic Cardiomyopathy Associated With Thin-Filament Gene Mutations
    Coppini, Raffaele
    Ho, Carolyn Y.
    Ashley, Euan
    Day, Sharlene
    Ferrantini, Cecilia
    Girolami, Francesca
    Tomberli, Benedetta
    Bardi, Sara
    Torricelli, Francesca
    Cecchi, Franco
    Mugelli, Alessandro
    Poggesi, Corrado
    Tardiff, Jil
    Olivotto, Iacopo
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (24) : 2589 - 2600
  • [33] Location of mutations within the PKD2 gene influences clinical outcome.
    Hateboer, N
    Peters, D
    San-Millan, J
    Bogdanova, N
    Breuning, M
    Coto, E
    Von Dijk, M
    Jeffery, S
    Saggar-Malik, A
    Torra, R
    Veldhuisen, B
    Krawczak, M
    Ravine, D
    KIDNEY INTERNATIONAL, 1999, 55 (06) : 2573 - 2573
  • [34] Clinical and Radiological Outcome of Patients Suffering From Chronic Pancreatitis Associated With Gene Mutations
    Frulloni, Luca
    Scattolini, Chiara
    Graziani, Rossella
    Cavestro, Giulia Martina
    Pravadelli, Cecilia
    Amodio, Antonio
    Manfredi, Riccardo
    Scarpa, Aldo
    Vantini, Italo
    PANCREAS, 2008, 37 (04) : 371 - 376
  • [35] Myeloproliferative Patients with Calreticulin Gene Mutations: Clinical Manifestations and Outcome, a Single Institution Experience
    Abu-Tineh, Mohammad
    Alshurafa, Awni
    Qasim, Hana
    Ansari, Soubiya
    Faraj, Hazem
    Alateeg, Saif
    Kurt, Onur
    Akiki, Susanna Jane
    Yassin, Mohamed A.
    BLOOD, 2022, 140 : 12280 - 12281
  • [36] Mutations in the Gene Encoding DMT1: Clinical Presentation Treatment
    Iolascon, Achille
    De Falco, Luigia
    SEMINARS IN HEMATOLOGY, 2009, 46 (04) : 358 - 370
  • [37] Follicular lymphoma: Molecular predictors of treatment response and clinical outcome
    Weigert, O.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 14 - 14
  • [38] Idiotype vaccine and dose-adjusted EPOCH-rituximab treatment untreated mantle cell lymphoma: Preliminary report on clinical outcome and analysis of immune response.
    Wilson, WH
    Neelapu, S
    Rosenwald, A
    White, T
    Dunleavy, K
    Pittaluga, S
    Hakim, F
    Stetler-Stevenson, M
    Steinberg, S
    Jaffe, ES
    Gress, R
    Wright, G
    Staudt, L
    Janik, J
    Kwak, L
    BLOOD, 2003, 102 (11) : 105A - 106A
  • [39] CYTOKINE GENE POLYMORPHISMS AND RESPONSE TO IMMUNOSUPPRESSIVE TREATMENT OF ACQUIRED APLASTIC ANEMIA IN KOREA
    Lee, Y. G.
    Shin, D. Y.
    Kim, I. H.
    Yoon, S. S.
    Park, S.
    Kim, B. K.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 686 - 686
  • [40] Mutations in the low-density lipoprotein receptor gene in Swedish familial hypercholesterolaemia patients:: clinical expression and treatment response
    Ekström, U
    Abrahamson, M
    Wallmark, A
    Florén, CH
    Nilsson-Ehle, P
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1998, 28 (09) : 740 - 747
12345